Burrows Scott L 4
4 · Spyre Therapeutics, Inc. · Filed Dec 22, 2023
Insider Transaction Report
Form 4
Burrows Scott L
Chief Financial Officer
Transactions
- Award
Common Stock
2023-12-22+134,953→ 134,953 total
Footnotes (1)
- [F1]Represents 134,953 restricted stock units ("RSUs") granted under the Spyre Therapeutics, Inc. 2016 Equity Incentive Plan, as Amended and Restated. Each RSU represents a contingent right to receive, upon vesting, one share of common stock, par value $0.0001 per share, of the Issuer. The RSUs vest as to one-fourth on each anniversary of September 1, 2023, subject to the Reporting Person's continued employment with the Issuer.